Drugs@FDA: FDA-Approved Drugs
Biologic License Application (BLA): 761473
Company: FORMYCON AG
Company: FORMYCON AG
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| NUFYMCO | RANIBIZUMAB-LEYK | 6MG/ML | INJECTION | Prescription | None | No | No |
| NUFYMCO | RANIBIZUMAB-LEYK | 10MG/ML | INJECTION | Prescription | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 12/18/2025 | ORIG-1 | Approval | N/A |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/761473Orig1s000ltr.pdf |